Ascendis Pharma A/S (ASND) - Financial and Strategic SWOT Analysis Review

  • ID: 4284893
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4

Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, transcon treprostinil, transcon ranibizumab and transcon peptides. Its transcon ranibizumab is used for the treatment of age related macular edema and other ophthalmic indications. Ascendis conducts research and develops new drug candidates for treatment. The company’s products are used in the therapeutic areas of diabetes, growth hormone deficiency, endocrinology, pulmonary arterial hypertension and others. It partners with pharmaceutical and biotechnology companies to develop new products. The company has its research and development facilities in Germany and Denmark. Ascendis is headquartered in Hellerup, Denmark.

Ascendis Pharma A/S Key Recent Developments

Nov 16, 2017: Ascendis Pharma Reports Third Quarter 2017 Financial Results
Aug 18, 2017: Ascendis Pharma Reports Second Quarter 2017 Financial Results
Jun 22, 2017: Ascendis Pharma Adopts New Global Communications Model With Fuze
May 23, 2017: Ascendis Pharma Reports First Quarter 2017 Financial Results
Mar 31, 2017: Ascendis Pharma Announces Updated Time for April 3 Conference Call to Review ENDO 2017 Data

This comprehensive SWOT profile of Ascendis Pharma A/S provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ascendis Pharma A/S including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Ascendis Pharma A/S - Key Information
  • Ascendis Pharma A/S - Overview
  • Ascendis Pharma A/S - Key Employees
  • Ascendis Pharma A/S - Key Employee Biographies
  • Ascendis Pharma A/S - Key Operational Heads
  • Ascendis Pharma A/S - Major Products and Services
  • Ascendis Pharma A/S - History
  • Ascendis Pharma A/S - Company Statement
  • Ascendis Pharma A/S - Locations And Subsidiaries
  • Ascendis Pharma A/S - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Ascendis Pharma A/S - Business Description
  • Ascendis Pharma A/S - Corporate Strategy
  • Ascendis Pharma A/S - SWOT Analysis
  • SWOT Analysis - Overview
  • Ascendis Pharma A/S - Strengths
  • Ascendis Pharma A/S - Weaknesses
  • Ascendis Pharma A/S - Opportunities
  • Ascendis Pharma A/S - Threats
  • Ascendis Pharma A/S - Key Competitors
Section 3 - Company Financial Performance Charts
  • Ascendis Pharma A/S - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Ascendis Pharma A/S, Key Information
  • Ascendis Pharma A/S, Key Ratios
  • Ascendis Pharma A/S, Share Data
  • Ascendis Pharma A/S, Major Products and Services
  • Ascendis Pharma A/S, History
  • Ascendis Pharma A/S, Key Employees
  • Ascendis Pharma A/S, Key Employee Biographies
  • Ascendis Pharma A/S, Key Operational Heads
  • Ascendis Pharma A/S, Other Locations
  • Ascendis Pharma A/S, Subsidiaries
  • Ascendis Pharma A/S, Key Manufacturing facilities
  • Ascendis Pharma A/S, Key Competitors
  • Ascendis Pharma A/S, SWOT Analysis
  • Ascendis Pharma A/S, Ratios based on current share price
  • Ascendis Pharma A/S, Annual Ratios
  • Ascendis Pharma A/S, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Ascendis Pharma A/S, Performance Chart
  • Ascendis Pharma A/S, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown